Cargando…
Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells
Neuroblastoma (NB) is the most common extracranial solid tumour in infants. Unfortunately, most children present with advanced disease and have a poor prognosis. In the present study, we evaluated the role of the peroxisome proliferator-activated receptor γ (PPARγ) agonist rosiglitazone (RGZ) in two...
Autores principales: | Cellai, I, Benvenuti, S, Luciani, P, Galli, A, Ceni, E, Simi, L, Baglioni, S, Muratori, M, Ottanelli, B, Serio, M, Thiele, C J, Peri, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360542/ https://www.ncbi.nlm.nih.gov/pubmed/16969347 http://dx.doi.org/10.1038/sj.bjc.6603344 |
Ejemplares similares
-
In vivo effects of rosiglitazone in a human neuroblastoma xenograft
por: Cellai, I, et al.
Publicado: (2010) -
PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008) -
Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-γ
por: Ribatti, D, et al.
Publicado: (2006) -
Hexokinase 2 is a determinant of neuroblastoma metastasis
por: Edry Botzer, Liat, et al.
Publicado: (2016) -
Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells
por: Armstrong, J L, et al.
Publicado: (2005)